A significant strategy to manage Alzheimer’s disease involves maintaining the levels of acetylcholine in the synaptic cleft through inhibiting acetylcholinesterase [10,11]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.